Targeted Repair of Vascular Injury by Adipose‐Derived Stem Cells Modified with P‐Selectin Binding Peptide

Abstract

Percutaneous coronary intervention for coronary artery disease treatment often results in pathological vascular injury, characterized by P‐selectin overexpression. Adipose‐derived stem cells (ADSCs) therapeutic efficacy remains elusive due to poor ADSCs targeting and retention in injured vessels. Here, conjugated P‐selectin binding peptide (PBP) to polyethylene glycol‐conjugated phospholipid derivative (DMPE‐PEG) linkers (DMPE‐PEG‐PBP; DPP) are used to facilitate the modification of PBP onto ADSCs cell surfaces via hydrophobic interactions between DMPE‐PEG and the phospholipid bilayer. DPP modification neither has influence on ADSCs proliferation nor apoptosis/paracrine factor gene expression. A total of 5 × 10−6 m DPP‐modified ADSCs (DPP‐ADSCs) strongly binds to P‐selectin‐displaying activated platelets and endothelial cells (ECs) in vitro and to wire‐injured rat femoral arteries when administered by intra‐arterial injection. Targeted binding of ADSCs shields injury sites from platelet and leukocyte adhesion, thereby decreasing inflammation at injury sites. Furthermore, targeted binding of ADSCs recovers injured ECs functionality and reduces platelet‐initiated vascular smooth muscle cells (VSMCs) chemotactic migration. Targeted binding of DPP‐human ADSCs to balloon‐injured human femoral arteries is also demonstrated in ex vivo experiments. Overall, DPP‐ADSCs promote vascular repair, inhibit neointimal hyperplasia, increase endothelium functionality, and maintain normal VSMCs alignment, supporting preclinical noninvasive utilization of DPP‐ADSCs for vascular injury.

Study on promoting the regeneration of grafted fat by cell-assisted lipotransfer

“…Primary fibroblasts and ADSCs were successfully isolated from human tissues and identified separately. ADSCs were identified by CD73+, CD90+, CD105+, CD31−, CD34− and CD45− [ 44 , 45 ], and by their ability to differentiate into adipogenic, chondrogenic and osteogenic ( Supplementary Fig. 1 ).…”

Research and clinical translation of trilayer stent-graft of expanded polytetrafluoroethylene for interventional treatment of aortic dissection

“…The latest decade has witnessed rapid progress in biomaterials and medical devices, in both fundamental research [ 44–51 ] and applications [ 52–59 ]. While medical materials have been much developed [ 60–68 ], it is still challenging to find a biomaterial-related cardiovascular device appropriate for interventional treatment.…”

Renal Endothelial Cell‐Targeted Extracellular Vesicles Protect the Kidney from Ischemic Injury

“…Cells were incubated in a humidified hypoxia incubator (Thermo Scientific) with 5% CO 2 , 1% O 2 , and 94% N 2 at 37 °C for 6 h and then reoxygenated with 95% air and 5% CO 2 for an additional 12 h, as previously reported. [ 20 ]…”